Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
3/28/2026, 12:00:00 AM
Presentation of positive late-breaking Phase 2 AMETHYST study data for litifilimab in cutaneous lupus erythematosus (CLE) at the 2026 American Academy of Dermatology Annual Meeting on 2026-03-28; medium importance is estimated as Phase 2 data for a breakthrough therapy typically results in ≥5% price movement, scheduled.
Korean Translation
2026-03-28로 예정된 2026년 미국피부과학회(AAD) 연례회의에서 피부 홍반성 루푸스(CLE) 츘료제 리티필리맙에 대한 긍정적인 후기 임상 2상 AMETHYST 연구 데이터 발표이며, 획기적 츘료제의 임상 데이터 발표는 통상 5% 이상의 주가 변동을 야기하므로 중간 중요도로 예정됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's earnings release for Q1 FY2027 is scheduled. A medium impact is estimated as earnings releases are key volatility drivers for retail stocks, expected.
5/21/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK 2026 Annual Meeting of Shareholders on May 20, 2026, scheduled.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM